ANAVEX LIFE SCIENCES CORP. (AVXL) Operating cash flow 2016–2025
ANAVEX LIFE SCIENCES CORP. (AVXL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$39.0MFY2025 · since FY2016: -$9.2M → -$39.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$39.0M | -26.7% |
| FY2024 | -$30.8M | -10.9% |
| FY2023 | -$27.8M | -14.6% |
| FY2022 | -$24.2M | +20.2% |
| FY2021 | -$30.4M | -42.7% |
| FY2020 | -$21.3M | -14.9% |
| FY2019 | -$18.5M | -47.2% |
| FY2018 | -$12.6M | -39.5% |
| FY2017 | -$9.0M | +2.4% |
| FY2016 | -$9.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice